Literature DB >> 7824284

Identification of alternatively spliced mRNAs encoding variants of MDK1, a novel receptor tyrosine kinase expressed in the murine nervous system.

T Ciossek1, B Millauer, A Ullrich.   

Abstract

A novel member of the eck/eph family of receptor tyrosine kinases (RTKs), termed mouse developmental kinase 1 (MDK1), was identified and shown to be closely related to the Eek, Ehk1/Cek7, Ehk2, Cek4/Mek4/hek and Sek/Cek8 subfamily. Northern blot analysis revealed MDK1 mRNA transcripts of 6.8, 5.7, 4.0, 3.2 and 2.6 kb that encode apparent splice variants. Sequence analyses of MDK1 cDNA clones from adult mouse brain predict the existence of at least five isoforms, including two truncated receptor variants lacking the kinase domain. Northern blot and in situ hybridization analysis indicate that in the adult mouse MDK1 RNA expression is restricted to brain, testes and spleen. The distinct patterns of MDK1 gene expression during mouse development suggest an important role in the formation of neuronal structures and possibly other morphogenic processes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7824284

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

Review 1.  Intracellular and extracellular regulation of ureteric bud morphogenesis.

Authors:  J Davies
Journal:  J Anat       Date:  2001-03       Impact factor: 2.610

2.  Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis.

Authors:  Johan Holmberg; Annika Armulik; Kirsten-André Senti; Karin Edoff; Kirsty Spalding; Stefan Momma; Rob Cassidy; John G Flanagan; Jonas Frisén
Journal:  Genes Dev       Date:  2005-02-15       Impact factor: 11.361

3.  EphrinA5-EphA7 complex induces apoptotic cell death via TNFR1.

Authors:  Haeryung Lee; Eunjeong Park; Yujin Kim; Soochul Park
Journal:  Mol Cells       Date:  2013-05-03       Impact factor: 5.034

4.  Regulation of topographic projection in the brain: Elf-1 in the hippocamposeptal system.

Authors:  P P Gao; J H Zhang; M Yokoyama; B Racey; C F Dreyfus; I B Black; R Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

5.  EphA7 signaling guides cortical dendritic development and spine maturation.

Authors:  Meredith A Clifford; Wardah Athar; Carrie E Leonard; Alexandra Russo; Paul J Sampognaro; Marie-Sophie Van der Goes; Denver A Burton; Xiumei Zhao; Rupa R Lalchandani; Mustafa Sahin; Stefano Vicini; Maria J Donoghue
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-18       Impact factor: 11.205

6.  Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas.

Authors:  D W Dawson; J S Hong; R R Shen; S W French; J J Troke; Y-Z Wu; S-S Chen; D Gui; M Regelson; Y Marahrens; H C Morse; J Said; C Plass; M A Teitell
Journal:  Oncogene       Date:  2007-01-29       Impact factor: 9.867

7.  EphA1 Activation Induces Neuropathological Changes in a Mouse Model of Parkinson's Disease Through the CXCL12/CXCR4 Signaling Pathway.

Authors:  Jianjun Ma; Zhidong Wang; Siyuan Chen; Wenhua Sun; Qi Gu; Dongsheng Li; Jinhua Zheng; Hongqi Yang; Xue Li
Journal:  Mol Neurobiol       Date:  2020-10-15       Impact factor: 5.590

8.  ELF-2, a new member of the Eph ligand family, is segmentally expressed in mouse embryos in the region of the hindbrain and newly forming somites.

Authors:  A D Bergemann; H J Cheng; R Brambilla; R Klein; J G Flanagan
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

9.  Genome-wide review of transcriptional complexity in mouse protein kinases and phosphatases.

Authors:  Alistair R R Forrest; Darrin F Taylor; Mark L Crowe; Alistair M Chalk; Nic J Waddell; Gabriel Kolle; Geoffrey J Faulkner; Rimantas Kodzius; Shintaro Katayama; Christine Wells; Chikatoshi Kai; Jun Kawai; Piero Carninci; Yoshihide Hayashizaki; Sean M Grimmond
Journal:  Genome Biol       Date:  2006-01-26       Impact factor: 13.583

10.  Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.

Authors:  Lin-Fang Wang; Emmanouil Fokas; Janko Juricko; An You; Frank Rose; Axel Pagenstecher; Rita Engenhart-Cabillic; Han-Xiang An
Journal:  BMC Cancer       Date:  2008-03-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.